BC

Investment firm

Broadfin Capital

Private equity, Venture debt

WebsiteCrunchbase profileNew York City·United States10known portfolio companies1person tracked16co-investors

Broadfin Capital is a private equity firm and venture debt provider. The one team member on file is in New York City, United States. The known portfolio counts 10 companies, including Sonendo, Ardelyx, Edesa Biotech, Iovance Biotherapeutics, Contrafect and Heron Therapeutics.

Is Broadfin Capital a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Who to pitch at Broadfin Capital

Broadfin Capital portfolio companies (10)

  • Sonendo
  • Ardelyx
  • Edesa Biotech
  • Iovance Biotherapeutics
  • Contrafect
  • Heron Therapeutics
  • Arch Oncology
  • BioDelivery Sciences
  • Strata Skin Sciences
  • Recro Pharma

Co-investors

Funds that share portfolio companies with Broadfin Capital.

Similar funds

Showing 20 of 100

About Broadfin Capital

The firm's listing covers sector Healthcare, and focus areas Biotech, MedTech, Medical Devices and Pharma; known deals cluster at Late-Stage.

The contact to approach at Broadfin Capital is Kevin Kotler (Investor).

Across the known portfolio, 16 co-investors appear alongside Broadfin Capital, including Rubric Capital Management, Fjord Capital and SEB Private Equity.

Frequently asked questions

What is Broadfin Capital?

Broadfin Capital is a private equity firm and venture debt provider whose one person on file is in New York City, United States, with a known portfolio of 10 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Broadfin Capital invest in?

Listed sectors include Healthcare; listed focus areas include Biotech, MedTech, Medical Devices and Pharma. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Broadfin Capital invest at?

The known deals of Broadfin Capital include Late-Stage rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Broadfin Capital?

One person at Broadfin Capital is on file, listed as a contact for the firm, with their own profile page.

How do I contact Broadfin Capital?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The one person attached to the firm has their own page, which shows whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal